• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×

working
  • 31 Oct 2025

Broad-Based Revenue Strength Drives 3Q:25 EPS Above Our Estimate; We Increase Our 2025 EPS Estimate And Introduce Our 2027 Forecast; Raise Price Target To $260 (From $253)


CRA INTERNATIONAL (CRAI:NYSE) | 0 0 0.0%


  • Sidoti & Company
    • Marc Riddick, CFA

    • 10 pages


 

Reported EPS of $2.06 was $0.24 above our estimate, led by revenue of $185.9 million (up 10.8% year over year and $8.5 million above our estimate). Four practices (Antitrust & Competition Economics, Energy, Intellectual Property and Finance) reported double-digit revenue growth year over year. Management increased 2025 guidance to total revenue (on a constant currency basis) of $740-$748 million (up from $730-$745 million) and adjusted EBITDA margin of 12.6%-13.0% (from 12.3%-13.0%). We increase our EPS estimate to $8.25 (from $8.05) in 2025, maintain our estimate of $8.83 in 2026 and introduce our estimate of $9.92 in 2027. Our free cash flow per share (excluding the add back of stock-based compensation expense) estimate of $11.41 (from $11.39) in 2025, $11.82 in 2026 and $12.80 in 2027 imply respective FCF yields of 6.2%, 6.4% and 6.9%. Our new $260 price target is based on 24x our 2027 EPS estimate of $9.92, plus projected year-end 2027 net cash per share of $21.82. Our prior $253 price target was based on 27x our 2026 EPS estimate of $8.83, plus our previous projected year-end 2026 net cash per share of $14.39. Our reduced multiple is due to the expanded time horizon with the introduction of our 2027 estimates. On a P/E only basis, our price target implies a 26.2x multiple of our 2027 EPS estimate, which we view as consistent with high level consulting peers. Strong fundamentals, high client retention and free cash flow support the valuation and the moderate risk rating, in our view. CRA International is scheduled to present and host 1x1 meetings at the Sidoti Year-End Virtual Investor Conference on December 10-11.

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here
See all the research we have on this company.

Broad-Based Revenue Strength Drives 3Q:25 EPS Above Our Estimate; We Increase Our 2025 EPS Estimate And Introduce Our 2027 Forecast; Raise Price Target To $260 (From $253)


CRA INTERNATIONAL (CRAI:NYSE) | 0 0 0.0%


  • Published: 31 Oct 2025
  • Author: Marc Riddick, CFA
  • Pages: 10
  • Sidoti & Company


Reported EPS of $2.06 was $0.24 above our estimate, led by revenue of $185.9 million (up 10.8% year over year and $8.5 million above our estimate). Four practices (Antitrust & Competition Economics, Energy, Intellectual Property and Finance) reported double-digit revenue growth year over year. Management increased 2025 guidance to total revenue (on a constant currency basis) of $740-$748 million (up from $730-$745 million) and adjusted EBITDA margin of 12.6%-13.0% (from 12.3%-13.0%). We increase our EPS estimate to $8.25 (from $8.05) in 2025, maintain our estimate of $8.83 in 2026 and introduce our estimate of $9.92 in 2027. Our free cash flow per share (excluding the add back of stock-based compensation expense) estimate of $11.41 (from $11.39) in 2025, $11.82 in 2026 and $12.80 in 2027 imply respective FCF yields of 6.2%, 6.4% and 6.9%. Our new $260 price target is based on 24x our 2027 EPS estimate of $9.92, plus projected year-end 2027 net cash per share of $21.82. Our prior $253 price target was based on 27x our 2026 EPS estimate of $8.83, plus our previous projected year-end 2026 net cash per share of $14.39. Our reduced multiple is due to the expanded time horizon with the introduction of our 2027 estimates. On a P/E only basis, our price target implies a 26.2x multiple of our 2027 EPS estimate, which we view as consistent with high level consulting peers. Strong fundamentals, high client retention and free cash flow support the valuation and the moderate risk rating, in our view. CRA International is scheduled to present and host 1x1 meetings at the Sidoti Year-End Virtual Investor Conference on December 10-11.

More Content

More Content

Our 3Q:25 EPS Estimate Of $1.82 Implies Modest Growth Against A Strong Year-Ago Comparison; Steady 2025-2026 EPS Growth, Free Cash Flow Gains Support $253 Price Target, In Our View

Companies: CRA INTERNATIONAL

Sidoti & Company

We Maintain Our 3Q:25 Loss Per Share Estimate Of $0.08; While Macroeconomic And Political Concerns Weight On Shares, We Think Free Cash Flow And Valuation Support Our $7 Target

Companies: Conduent Inc

Sidoti & Company

Takeaways From The Sidoti Conference: CRAI Remains Well Positioned For Anticipated Ongoing Economic Uncertainty And Potential M&A Growth, In Our View; Raise Target To $253 (From $244)

Companies: CRA INTERNATIONAL

Sidoti & Company

Energy Morning - 3 November 2025

Companies: NOR AKSO ORSTED OKEA IPCO ODL SDLPF SDRL RIG SUBC NOL HEX AKSO ORSTED DNO VWS DOFG BORR RIG SUBC BNOR DNO OKEA HEX SDRL

ABG Sundal Collier

Revenue Gains Exceeded Our Expectations, 2Q:25 EPS Missed Our Estimate By $0.12 Due To Higher Interest Expenses; Trim Our 2025 Estimate And Price Target To $244 (From $247)

Companies: CRA INTERNATIONAL

Sidoti & Company
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • Chrome Extension
  • iOS and Android Apps
  • LLM Feed
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2025

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Actinver
      • Actio Advisors
      • Asset TV
      • Astris Advisory
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Bowsprit Partners Limited
      • Brand Communications
      • Brokerlink
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • MUFG Corporate Markets IR
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD / Progressive
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Edge Group
      • The Life Sciences Division
      • ThinkFront
      • Tring Triangle
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • xxxxxx_deleted
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Allenby Capital
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Longspur Clean Energy
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • Tring Triangle
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In